Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer
PaperCitations, authors & open-access status
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 88 citations, 2024 year and bronze oa status.
88
Citations
2024
Year
bronze
OA Status